TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.08B
AUM Growth
+$170M
(+5.9%)
Cap. Flow
-$52.3M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
31.64%
Holding
198
New
2
Increased
42
Reduced
42
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$41.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$22.5M |
| 3 |
United Therapeutics
UTHR
|
$13.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.4M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.7M |
Top Sells
| 1 |
Elevance Health
ELV
|
$21.8M |
| 2 |
Illumina
ILMN
|
$21.3M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
Waters Corp
WAT
|
$18.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
$15.8M |
Sector Composition
| 1 | Healthcare | 95.67% |
| 2 | Real Estate | 2.94% |
| 3 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
51
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $15.8M | 0.51% |
45,983
+5,594
| +14% | +$1.92M |
|
52
Sarepta Therapeutics
SRPT
$1.98B
| $15M | 0.49% |
193,224
+64,237
| +50% | +$4.99M |
|
53
Adaptive Biotechnologies
ADPT
$1.96B
| $13.8M | 0.45% |
337,722
| – | – |
|
54
IQVIA
IQV
$31.4B
| $13.8M | 0.45% |
56,766
-13,100
| -19% | -$3.17M |
|
|
GTHX
55
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $13.7M | 0.45% |
624,369
+232,615
| +59% | +$5.1M |
|
|
IMAB
56
I-MAB
IMAB
$380M
| $13.6M | 0.44% |
162,580
-4,316
| -3% | -$362K |
|
57
Mettler-Toledo International
MTD
$26.1B
| $13.6M | 0.44% |
9,800
| – | – |
|
|
MRTX
58
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.5M | 0.44% |
83,784
| – | – |
|
|
ARNA
59
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $13.4M | 0.44% |
196,385
| – | – |
|
60
Ionis Pharmaceuticals
IONS
$9.64B
| $12.9M | 0.42% |
322,521
+106,150
| +49% | +$4.23M |
|
61
Ultragenyx Pharmaceutical
RARE
$3.04B
| $12.8M | 0.42% |
134,590
+37,110
| +38% | +$3.54M |
|
62
BioNTech
BNTX
$24.1B
| $12.8M | 0.42% |
57,073
-11,741
| -17% | -$2.63M |
|
63
Novartis
NVS
$248B
| $12.4M | 0.4% |
136,225
| – | – |
|
64
CVS Health
CVS
$93B
| $12.3M | 0.4% |
147,453
-72,542
| -33% | -$6.05M |
|
65
Iovance Biotherapeutics
IOVA
$800M
| $12.2M | 0.4% |
468,538
-52,057
| -10% | -$1.35M |
|
66
Jazz Pharmaceuticals
JAZZ
$7.99B
| $12M | 0.39% |
67,456
| – | – |
|
67
Ventas
VTR
$30.7B
| $11.9M | 0.39% |
208,108
| – | – |
|
|
ALXN
68
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.8M | 0.38% |
64,453
-46,240
| -42% | -$8.49M |
|
|
AMED
69
DELISTED
Amedisys
AMED
| $11.8M | 0.38% |
48,070
+28,675
| +148% | +$7.02M |
|
70
Denali Therapeutics
DNLI
$2.24B
| $11.8M | 0.38% |
150,086
| – | – |
|
71
BridgeBio Pharma
BBIO
$9.91B
| $11.5M | 0.37% |
188,767
+114,053
| +153% | +$6.95M |
|
|
KRTX
72
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $11.5M | 0.37% |
100,458
+15,222
| +18% | +$1.74M |
|
|
ALLK
73
DELISTED
Allakos
ALLK
| $11.4M | 0.37% |
133,045
-30,600
| -19% | -$2.61M |
|
|
DCPH
74
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.3M | 0.37% |
307,703
| – | – |
|
75
Owens & Minor
OMI
$423M
| $11.3M | 0.37% |
266,023
| – | – |
|